患者血液管理市场规模、份额和增长分析：按产品、组件、最终用户和地区 - 2024-2031 年行业预测

2023年患者血液管理市场规模估值为137.9亿美元，从2024年的146.6亿美元增长到2032年的239亿美元，在预测期内（2025-2032年）复合年增长率为6.30，预计将增长%。

在慢性病盛行率上升、外科手术数量增加以及人们对 PBM 益处的认识不断提高的推动下，全球患者血液管理 (PBM) 市场正处于强劲增长轨道。这项策略方法旨在加强对需要输血的患者的护理，最终改善结果并最大限度地减少对输血的依赖。心血管疾病、癌症和血液疾病等慢性疾病是外科手术增加输血需求的主要原因。然而，医疗保健提供者越来越多地实施 PBM 策略，以减少感染疾病和免疫反应等相关风险。这一转变的重点是改善手术结果和减少併发症，从而推动市场对 PBM 解决方案的需求。此外，人们对输血创新替代方案的认识不断增强，全球 PBM 的采用也不断增加。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析

病患血液管理市场规模：依产品分类

• 市场概况
• 装置
• 血液处理设备
  • 离心式
  • 血球处理设备
• 输血设备
  • 血浆分离装置
  • 细胞救援系统
• 血液培养筛检装置
  • 自动血液培养系统
  • 支援设备
• 诊断和测试设备
  • 聚合酵素链锁反应
  • 血液分析仪
  • 血型检测仪
  • 次世代定序（NGS）平台
  • 其他的
• 血液储存装置
  • 冰箱
  • 冷冻库
• 配件
• 注射器和针头
• 管瓶和管子
• 血袋
• 其他配件
• 试剂和套件
• 文化媒体
• 血型测定试剂
• 玻片染色
• 检测试剂套件
• 其他的
• 软体
• 血库和输血软体
• 其他的

病患血液管理市场规模：依组成部分

• 市场概况
• 全血
• 血液成分

患者血液管理市场规模：依最终用户分类

• 市场概况
• 医院
• 血库

病患血液管理市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Haemonetics Corporation（USA）
• Macopharma（France）
• Terumo Corporation（Japan）
• B. Braun SE（Germany）
• Grifols, SA（Spain）
• Asahi Kasei Corporation（Japan）
• BioMerieux SA（France）
• LivaNova PLC（UK）
• Fresenius Kabi AG（Germany）
• Roche Holding AG（Switzerland）
• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Medtronic plc.（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Cardinal Health（USA）
• Teleflex Incorporated（USA）
• Stryker Corporation（USA）

结论和建议

Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

The global patient blood management (PBM) market is on a robust growth trajectory, fueled by rising chronic disease prevalence, an uptick in surgical procedures, and heightened awareness of PBM benefits. This strategic approach aims to enhance care for patients needing blood transfusions, ultimately improving outcomes and minimizing transfusion reliance. Chronic diseases like cardiovascular disorders, cancer, and blood disorders are major contributors to surgical needs, intensifying transfusion requirements. However, healthcare providers are increasingly implementing PBM strategies to mitigate associated risks such as infections and immune reactions. This shift emphasizes improving surgical results and reducing complications, propelling market demand for PBM solutions. Furthermore, awareness of innovative alternatives to transfusions is increasingly promoting the adoption of PBM practices on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Patient Blood Management Market Segmental Analysis

Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Patient Blood Management Market

The Patient Blood Management market is driven by significant advancements in transfusion medicine, which have transformed the landscape of blood management practices. Innovations in techniques and technologies have greatly enhanced the safety, efficiency, and effectiveness of blood transfusions. As a result, healthcare providers are increasingly embracing patient blood management strategies to optimize patient outcomes. These developments not only reduce the risks associated with transfusions but also foster a greater understanding of the importance of prudent blood usage. Consequently, the ongoing evolution in transfusion medicine is playing a pivotal role in propelling the growth of the Patient Blood Management market.

Restraints in the Patient Blood Management Market

The Patient Blood Management market faces several restraints, primarily due to the challenges associated with altering established transfusion practices. Transitioning towards these new management strategies requires a significant shift away from traditional methods and medical standards. This shift can be hindered by resistance to change from healthcare professionals, as well as the need to accommodate individual physician preferences. Moreover, ensuring that adequate training and education are provided to facilitate understanding and acceptance of these innovative practices poses additional hurdles. As a result, these factors collectively impede the broader implementation and acceptance of patient blood management methodologies in clinical settings.

Market Trends of the Patient Blood Management Market

In the global Patient Blood Management market, a notable trend is the heightened emphasis on personalized and evidence-based transfusion practices, driven by a growing awareness of the risks associated with indiscriminate blood use. Healthcare providers are increasingly adopting tailored transfusion strategies that align with individual patient needs and clinical conditions, steering away from the traditional one-size-fits-all approach. This shift not only aims to enhance patient safety by reducing the likelihood of transfusion reactions and infections but also seeks to lower healthcare costs through optimized blood utilization. Consequently, hospitals and healthcare systems are investing in technologies and training that support this patient-centric model, indicating a transformational shift in blood management practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Patient Blood Management Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Blood Processing Devices
  • Centrifuge
  • Blood Cell Processors
• Blood Transfusion Devices
  • Apheresis Machines
  • Cell Salvage Systems
• Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Equipment
• Diagnostic & Testing Instruments
  • Polymerase Chain Reaction
  • Hematology Analyzer
  • Blood Grouping Analyzers
  • Next-Generation Sequencing (Ngs) Platforms
  • Others
• Blood Storage Devices
  • Refrigerator
  • Freezers
• Accessories
• Syringes & Needles
• Vials & Tubes
• Blood Bags
• Other Accessories
• Reagents And Kits
• Culture Media
• Blood Typing Reagents
• Slide Staining
• Assay Kits
• Others
• Software
• Blood Bank And Transfusion Software
• Others

Global Patient Blood Management Market Size by Component & CAGR (2025-2032)

• Market Overview
• Whole Blood
• Blood Components

Global Patient Blood Management Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Blood Banks

Global Patient Blood Management Market Size & CAGR (2025-2032)

• North America (Product, Component, End User)
  • US
  • Canada
• Europe (Product, Component, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Component, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Component, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Component, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations